Article Information
History
- January 1, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 1, 2022 - 16:18).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ariel Israel, M.D., Ph.D.1,*,
- Alejandro A. Schäffer, Ph.D.2,
- Eugene Merzon, M.D.1,3,
- Ilan Green, M.D.1,4,
- Eli Magen, M.D., Ph.D.1,5,
- Avivit Golan-Cohen, M.D.1,4,
- Shlomo Vinker, M.D., M.H.A.1,4 and
- Eytan Ruppin, M.D., Ph.D2
- 1Leumit Health Services, Israel
- 2Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD USA
- 3Adelson School of Medicine, Ariel University, Ariel, Israel
- 4Department of Family Medicine, Sackler Faculty of Medicine, Tel-Aviv University, Israel
- 5Medicine C Department, Clinical Immunology and Allergy Division, Barzilai University Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel
- ↵*Corresponding Author:
Ariel Israel, MD, PhD, Head of Leumit Research Institute, Leumit Health Services, Telephone: +972-58-5333212, Email: dr.ariel.israel{at}gmail.com